Zusammenfassung
In der Epidermis des Menschen werden zunehmend Transmitter und Rezeptoren gefunden,
die ursprünglich ausschließlich im Nervensystem vermutet wurden. Hierzu zählen unter
anderem Glutamat-, Acetylcholin- und Purinrezeptoren. Die einzelnen Rezeptorfamilien
beeinflussen dabei sowohl die Proliferation und Differenzierung des Keratinozyten
als auch die Barrierefunktion der Epidermis. Am Beispiel keratinozytärer Glutamatrezeptoren
werden Transmitterfunktionen in der Epidermis beschrieben, die ursprünglich exklusiv
dem Nervensystem zugeschrieben wurden.
Abstract
Transmitters and receptors which were originally presumed to be located exclusively
in the nervous system are increasingly being found in human epidermis. Among these
are glutamate, acetylcoline and purin receptors. The individual receptor families
influence the proliferation, differentiation of the keratinocytes as well as the barrier
function of the epidermis. Using keratinocytic glutamate receptors, this article describes
transmitter functions in the epidermis which were originally attributed solely to
the nervous system.
Literatur
- 1
Kurzen H, Wessler I, Kirkpatrick C J, Kawashima K, Grando S A.
The non-neuronal cholinergic system of human skin.
Horm Metab Res.
2007;
39
125-135
- 2
Pullar C E, Rizzo A, Isseroff R R.
beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a
catecholamine synthesis network in the epidermis.
J Biol Chem.
2006;
281
21 225-21 235
- 3
Greig A V, Linge C, Cambrey A, Burnstock G.
Purinergic receptors are part of a signaling system for keratinocyte proliferation,
differentiation, and apoptosis in human fetal epidermis.
J Invest Dermatol.
2003;
121
1145-1149
- 4
Grando S A, Pittelkow M R, Schallreuter K U.
Adrenergic and cholinergic control in the biology of epidermis: physiological and
clinical significance.
J Invest Dermatol.
2006;
126
1948-1965
- 5
Inoue K, Hosoi J, Denda M.
Extracellular ATP has stimulatory effects on the expression and release of IL-6 via
purinergic receptors in normal human epidermal keratinocytes.
J Invest Dermatol.
2007;
127
362-371
- 6
Hardingham G E, Bading H.
The Yin and Yang of NMDA receptor signalling.
Trends Neurosci.
2003;
26
81-89
- 7
Kew J N, Kemp J A.
Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Psychopharmacology.
2005;
179
4-29
- 8
Fischer M, Glanz D, William T, Klapperstück T, Wohlrab J, Marsch W C.
N-methyl-D-aspartate-receptors influence the intracellular calcium concentration of
keratinocytes.
Exp Dermatol.
2004;
13
512-519
- 9
Fischer M, William T, Helmbold P, Wohlrab J, Marsch W C.
Expression of epidermal N-methyl-D-aspartate receptors (NMDAR1) depends on formation
of the granular layer-analysis in diseases with parakeratotic cornification.
Arch Dermatol Res.
2004;
296
157-162
- 10
Fischer M, Fiedler E, Seidel C, Glanz D, Helmbold P, Meiss F, Dammann R.
Cultivated keratinocytes express N-methyl-D-aspartate-receptors of the NMDAR2D-type.
Arch Dermatol Res.
2006;
297
316-318
- 11
Fuziwara S, Inoue K, Denda M.
NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis.
J Invest Dermatol.
2003;
120
1023-1029
- 12
Genever P G, Maxfield S J, Kennovin G D, Maltman J, Bowgen C J, Raxworthy M J, Skerry T M.
Evidence for a novel glutamate-mediated signaling pathway in keratinocytes.
J Invest Dermatol.
1999;
112
337-342
- 13
Morhenn V B, Waleh N S, Mansbridge J N, Unson D, Zolotorev A, Cline P, Toll L.
Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes.
Eur J Pharmacol.
1994;
268
409-414
- 14
Morhenn V B, Murakami M, O’Grady T, Nordberg J, Gallo R L.
Characterization of the expression and function of N-methyl-D-aspartate receptor in
keratinocytes.
Exp Dermatol.
2004;
13
505-511
- 15
Nahm W K, Philpot B D, Adams M M, Badiavas E V, Zhou L H, Butmarc J, Bear M F, Falanga V.
Significance of N-methyl-D-Aspartate (NMDA) Receptor-mediated signalling in human
keratinocytes.
J Cell Physiol.
2004;
200
309-317
- 16
Menon G K, Elias P M.
Ultrastructural localization of calcium in psoriatic and normal human epidermis.
Arch Dermatol.
1991;
127
57-63
- 17
Wu S Z, Jiang S, Sims T J, Barger S W.
Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists.
Neurosci Res.
2005;
79
638-643
- 18
Kinkelin I, Bröcker E B, Koltzenburg M, Carlton S M.
Localization of ionotropic glutamate receptors in peripheral axons of human skin.
Neurosci Lett.
2000;
283
149-152
- 19
Miller K E, Richards B A, Kriebel R M.
Glutamine-, glutamine synthetase, glutamate dehydrogenase- and pyruvate carboxylase-immunoreactivities
in the rat dorsal root ganglion and peripheral nerve.
Brain Research.
2002;
945
202-211
- 20
Hoogduijn M J, Hitchcock I S, Smit N P, Gillbro J M, Schallreuter K U, Genever P G.
Glutamate receptors on human melanocytes regulate the expression of MiTF.
Pigment Cell Res.
2006;
19
58-67
- 21
Nordlind K, Johansson O, Liden S, Hokfelt T.
Glutamate- and aspartate-like immunoreactivities in human normal and inflamed skin.
Virchows Arch B Cell Pathol Incl Mol Pathol.
1993;
64
75-82
- 22
Fischer M, Glanz D, Presek P, Waltermann K, Brzoska T, Abels C.
The effect of L-glutamate and L-aspartate on the intracellular calcium concentration
of keratinocytes.
Exp Dermatol.
2007;
16
273
- 23
Ndoye A, Buchli R, Greenberg B, Nguyen V T, Zia S, Rodriguez J G, Webber R J, Lawry M A,
Grando S A.
Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes
in human epidermis.
J Invest Dermatol.
1998;
111
410-416
1 Vortrag beim wissenschaftlichen Jahres-Symposium der Berliner Stiftung für Dermatologie,
12. Mai 2007, Berlin.
Priv.-Doz. Dr. Matthias Fischer
HELIOS-Klinikum AueKlinik für Dermatologie und Venerologie
Gartenstr. 6
08280 Aue
Email: matthias.fischer@helios-kliniken.de